Issue 5, 2013

Development of a diketopiperazine-forming dipeptidyl Gly-Pro spacer for preparation of an antibody–drug conjugate

Abstract

We developed a novel diketopiperazine-forming dipeptidyl spacer aimed at application in antibody–drug conjugates. Enzymatic cleavage of a peptide linked to the Gly-Pro spacer resulted in formation of diketopiperazine, which was stable and non-toxic, and release of the parent drug.

Graphical abstract: Development of a diketopiperazine-forming dipeptidyl Gly-Pro spacer for preparation of an antibody–drug conjugate

Supplementary files

Article information

Article type
Concise Article
Submitted
05 Mar 2013
Accepted
05 Mar 2013
First published
06 Mar 2013

Med. Chem. Commun., 2013,4, 792-796

Development of a diketopiperazine-forming dipeptidyl Gly-Pro spacer for preparation of an antibody–drug conjugate

S. Manabe, H. Machida, Y. Aihara, M. Yasunaga, Y. Ito and Y. Matsumura, Med. Chem. Commun., 2013, 4, 792 DOI: 10.1039/C3MD00075C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements